Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Headache Week 2026: March 15-21.

The journal of headache and pain·2026
Same author

WHO's Global status report on neurology: mixed messages for people with headache disorders.

The journal of headache and pain·2026
Same author

Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity.

Journal of neurointerventional surgery·2025
Same author

Correction: The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical federation.

The journal of headache and pain·2025
Same author

The role of community pharmacists in managing common headache disorders, and their integration within structured headache services: position statement on behalf of the European Headache Federation (EHF) and Lifting The Burden (LTB: the Global Campaign against Headache), with the formal endorsement of the International Pharmaceutical Federation.

The journal of headache and pain·2025
Same author

The Global Campaign against Headache, aged 21: a critical self-appraisal, and plans for phase 2.

The journal of headache and pain·2025

Related Experiment Video

Updated: Jun 19, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Burden of headache.

Rigmor Jensen1, Birthe Krogh Rasmussen

  • 1Denmark Danish Headache Center, Glostrup and Hilleroed Hospital, Denmark. rigj@glostruphosp.kbhamt.dk

Expert Review of Pharmacoeconomics & Outcomes Research
|October 8, 2009
PubMed
Summary
This summary is machine-generated.

Headache disorders are a major cause of disability and lost workdays, yet they remain underdiagnosed and undertreated. Public health initiatives are needed to improve prevention and treatment, reducing societal and individual burdens.

More Related Videos

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Area of Science:

  • Neurology
  • Public Health
  • Pain Management

Background:

  • Headache disorders are the most prevalent pain conditions globally.
  • Migraine ranks high in disability-adjusted life years, and headaches cause significant work absence.
  • Chronic headaches affect 4-5% of the population, presenting unique treatment challenges.

Purpose of the Study:

  • To highlight the overlooked societal and individual burden of headache disorders.
  • To emphasize the need for improved diagnosis and treatment strategies.
  • To advocate for public health initiatives for headache prevention and management.

Main Methods:

  • Review of existing literature on headache prevalence and burden.
  • Analysis of economic and quality-of-life impacts of headache disorders.
  • Assessment of current treatment efficacy and gaps in care.

Main Results:

  • Headache disorders impose a substantial economic burden, costing at least $100 million per million inhabitants annually.
  • Chronic headaches significantly reduce quality of life and are often resistant to standard treatments.
  • A significant proportion of headache cases are secondary to other conditions or medication overuse, often ignored.

Conclusions:

  • Headache disorders are prevalent, disabling, underdiagnosed, and undertreated, necessitating urgent public health action.
  • Effective prevention and treatment strategies can reduce sickness absence and improve working abilities.
  • Societal acceptance and targeted interventions are crucial for mitigating the impact on individuals and families.